Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
494K
-
Shares change
-
+494K
-
Total reported value, excl. options
-
$4.42M
-
Value change
-
+$4.42M
-
Number of buys
-
28
-
Price
-
$8.96
Significant Holders of Lyra Therapeutics, Inc. - COM NEW (LYRA) as of Q2 2025
29 filings reported holding LYRA - Lyra Therapeutics, Inc. - COM NEW as of Q2 2025.
Lyra Therapeutics, Inc. - COM NEW (LYRA) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 494K shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (255K shares), SABBY MANAGEMENT, LLC (126K shares), VANGUARD GROUP INC (29.2K shares), BANK OF AMERICA CORP /DE/ (28.5K shares), Ikarian Capital, LLC (21.2K shares), GEODE CAPITAL MANAGEMENT, LLC (11K shares), STATE OF WISCONSIN INVESTMENT BOARD (10.5K shares), MORGAN STANLEY (2.16K shares), FMR LLC (1.75K shares), and BlackRock, Inc. (1.69K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.